What is BNCT (Boron Neutron Capture Therapy) offered at Edogawa Hospital?

BNCT is a type of radiation therapy that uses boron compounds taken up by cancer cells to trigger a reaction within tumor cells through neutron irradiation.

What stage of specific clinical research is Edogawa Hospital currently reporting progress on for BNCT?

Edogawa Hospital is reporting progress on Phase 2 (efficacy confirmation stage) of its specific clinical research on BNCT.

What positive treatment outcomes have been observed in the Phase 2 clinical research for BNCT at Edogawa Hospital?

Favorable treatment progress, including tumor disappearance (Complete Response: CR), has been confirmed in cases of recurrent breast cancer and untreated primary breast cancer.

What is the main difference in imaging evaluation used in the latest Phase 2 study compared to conventional BNCT?

The latest study uses FDG-PET to evaluate utility, whereas conventionally FBPA-PET has been used to evaluate boron compound accumulation, but FBPA-PET facilities are limited.

What is the purpose of 'specific clinical research' as defined in the article?

Specific clinical research is research aimed at evaluating treatments at medical institutions, based on the Clinical Research Act established by the Ministry of Health, Labour and Welfare.

AI News NQ Analysis

Edogawa Hospital, which provides BNCT (Boron Neutron Capture Therapy) as a self-pay medical service, reports progress on Phase 2 (efficacy confirmation) of its specific clinical research on BNCT

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is BNCT (Boron Neutron Capture Therapy) offered at Edogawa Hospital?: A: BNCT is a type of radiation therapy that uses boron compounds taken up by cancer cells to trigger a reaction within tumor cells through neutron irradiation.
Q: What stage of specific clinical research is Edogawa Hospital currently reporting progress on for BNCT?: A: Edogawa Hospital is reporting progress on Phase 2 (efficacy confirmation stage) of its specific clinical research on BNCT.
Q: What positive treatment outcomes have been observed in the Phase 2 clinical research for BNCT at Edogawa Hospital?: A: Favorable treatment progress, including tumor disappearance (Complete Response: CR), has been confirmed in cases of recurrent breast cancer and untreated primary breast cancer.
Q: What is the main difference in imaging evaluation used in the latest Phase 2 study compared to conventional BNCT?: A: The latest study uses FDG-PET to evaluate utility, whereas conventionally FBPA-PET has been used to evaluate boron compound accumulation, but FBPA-PET facilities are limited.
Q: What is the purpose of 'specific clinical research' as defined in the article?: A: Specific clinical research is research aimed at evaluating treatments at medical institutions, based on the Clinical Research Act established by the Ministry of Health, Labour and Welfare.